Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)
China flag China · Delayed Price · Currency is CNY
3.140
-0.080 (-2.48%)
May 20, 2026, 1:35 PM CST

SHE:002390 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
6,1066,1068,6298,5609,13614,423
Market Cap Growth
-5.29%-29.23%0.81%-6.31%-36.66%7.39%
Enterprise Value
5,6445,8948,8208,9329,84115,454
Last Close Price
3.223.224.474.264.466.95
PE Ratio
47.7950.7785.1129.8040.7252.86
Forward PE
-26.3326.3326.3329.3529.35
PS Ratio
1.121.091.431.331.442.23
PB Ratio
0.860.871.231.201.292.11
P/TBV Ratio
1.011.011.461.411.522.49
P/FCF Ratio
9.119.4416.9213.0721.1570.63
P/OCF Ratio
8.458.3413.5910.8315.4631.49
EV/Sales Ratio
1.041.051.461.381.552.39
EV/EBITDA Ratio
11.2311.9417.8214.4117.3320.14
EV/EBIT Ratio
18.2419.6131.1822.8429.5729.24
EV/FCF Ratio
8.429.1117.2913.6422.7875.68
Debt / Equity Ratio
0.060.060.110.120.200.21
Debt / EBITDA Ratio
0.850.881.571.332.421.82
Debt / FCF Ratio
0.640.681.541.283.226.93
Net Debt / Equity Ratio
-0.10-0.10-0.030.000.070.12
Net Debt / EBITDA Ratio
-1.46-1.37-0.460.050.871.03
Net Debt / FCF Ratio
-1.08-1.05-0.450.051.143.87
Asset Turnover
0.620.640.660.680.650.67
Inventory Turnover
4.844.734.855.155.225.76
Quick Ratio
2.812.632.232.021.651.56
Current Ratio
3.503.312.912.632.162.02
Return on Equity (ROE)
2.87%2.73%2.20%4.98%3.86%6.23%
Return on Assets (ROA)
2.20%2.13%1.93%2.57%2.14%3.43%
Return on Invested Capital (ROIC)
4.01%3.81%3.40%4.74%3.75%6.51%
Return on Capital Employed (ROCE)
4.30%4.20%3.90%5.40%4.70%7.70%
Earnings Yield
2.09%1.97%1.18%3.36%2.46%1.89%
FCF Yield
10.98%10.60%5.91%7.65%4.73%1.42%
Dividend Yield
2.86%2.79%1.34%1.41%1.35%0.86%
Payout Ratio
101.83%108.76%189.67%55.09%75.03%84.41%
Buyback Yield / Dilution
-0.44%0.26%0.67%-2.41%-2.79%-15.32%
Total Shareholder Return
2.42%3.05%2.01%-1.00%-1.44%-14.46%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.